These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 13787804)

  • 21. [Hemiplegia after serotherapy].
    THUREL R; GRENIER J; LUTIER F
    Sem Hop; 1953 Apr; 29(27):1349-50. PubMed ID: 13076398
    [No Abstract]   [Full Text] [Related]  

  • 22. Phrenic paralysis due to serum neuritis.
    SMITH HP; SMITH HP
    Am J Med; 1955 Nov; 19(5):808-13. PubMed ID: 13268482
    [No Abstract]   [Full Text] [Related]  

  • 23. [Antitetanus immunization of the newborn infant by vaccination during pregnancy. Clinical and experimental studies].
    CONDREA P; POENARU E; ESRIG M; FILIPESCO I
    Arch Roum Pathol Exp Microbiol; 1961 Dec; 20():549-64. PubMed ID: 13880828
    [No Abstract]   [Full Text] [Related]  

  • 24. [Active immunization in antitetanus prevention. Note on one of our experiences].
    BALLONI A
    Riv Ital Ig; 1962; 22():37-48. PubMed ID: 13864457
    [No Abstract]   [Full Text] [Related]  

  • 25. [Medico-social considerations on the present status of antitetanus prevention and the necessity of obligatory anatoxin vaccination].
    DE FRANCESCO L
    Ann Sanita Pubblica; 1962; 23():195-208. PubMed ID: 13884188
    [No Abstract]   [Full Text] [Related]  

  • 26. [Apropos of a case of fatal shock due to the first injection of antitetanus serum].
    FARAONE G
    Minerva Medicoleg; 1959; 79():111-4. PubMed ID: 13821534
    [No Abstract]   [Full Text] [Related]  

  • 27. [Favorable effect of serotherapy of tetanus with hyaluronidase].
    KLABUSAY L; LENFELD J; TRNAVSKY K
    Cesk Fysiol; 1956 Mar; 5(1):64-9. PubMed ID: 13374774
    [No Abstract]   [Full Text] [Related]  

  • 28. [Recurrent tetanus. Clinical, immunological and therapeutic considerations].
    Warter J; Mantz JM; Tempe JD; Otteni JC
    Presse Med (1893); 1967 May; 75(24):1223-6. PubMed ID: 6024174
    [No Abstract]   [Full Text] [Related]  

  • 29. [Studies on sensitizing properties of tetanus antigens in experimental conditions. IV. Passive sensitization. Specificity of the phenomenon of sensitization. Repeated desensitization].
    KASHINTSEVA NS; GIL'GUTEA ; SITSUKOVA ZIa
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Oct; 32():117-22. PubMed ID: 14454139
    [No Abstract]   [Full Text] [Related]  

  • 30. [Antitetanus serum eruption. (Report of three cases)].
    EGAMI M; HIRONE T
    Nihon Hifuka Gakkai Zasshi; 1962 Apr; 72():289-94. PubMed ID: 13889385
    [No Abstract]   [Full Text] [Related]  

  • 31. [Relation between allergy and anti-toxic tetanus immunity levels].
    KOVTUNOVICH LG; SHABLOVSKAIA EA
    Biull Eksp Biol Med; 1961 Nov; 52():85-8. PubMed ID: 14459015
    [No Abstract]   [Full Text] [Related]  

  • 32. The differences in immunizing capacity between various tetanus toxoids in active-passive immunization with human antitoxin.
    Cohen H; Peetoom F; van Ramshorst JD
    Prog Immunobiol Stand; 1970; 4():527-32. PubMed ID: 5482197
    [No Abstract]   [Full Text] [Related]  

  • 33. [SEROLOGICAL AND IMMUNOCHEMICAL STUDY OF ANTIBODIES APPEARING AFTER SEROTHERAPY DURING TETANUS].
    BURI JF; EYQUEM A; POCIDALO JJ
    Presse Med (1893); 1964 Jan; 72():81-6. PubMed ID: 14103059
    [No Abstract]   [Full Text] [Related]  

  • 34. [On the problem of seroprophylaxis and serotherapy of tetanus (Experimental study)].
    KRAVCHENKO AT; REZEPOV FF
    Voen Med Zh; 1960 Jan; 1():48-51. PubMed ID: 14411824
    [No Abstract]   [Full Text] [Related]  

  • 35. [Antitetanus vaccination].
    GIACCHE O
    Gazz Med Ital; 1960 Jan; 119():44-7. PubMed ID: 13827798
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the time required for the rise in antitetanus antibodies after a boster injection of anatoxin].
    BOIRON H; DARRASSE H
    C R Seances Soc Biol Fil; 1959; 153():2045-7. PubMed ID: 13802221
    [No Abstract]   [Full Text] [Related]  

  • 37. [Study of the sensitizing properties of tetanus toxoids in experiment. I].
    KASHINTSEVA NS; GIL'GUT EA; BOLGIN IuB; VASIL'EVA IV; SITSUKOVA ZIa
    Zh Mikrobiol Epidemiol Immunobiol; 1961 Jan; 32():126-9. PubMed ID: 13751654
    [No Abstract]   [Full Text] [Related]  

  • 38. [2 cases of prolonged thrombopenic purpura following an antidiphtheria-antitetanus vaccination. Splenectomy. Cure].
    BERNHEIM M; MOURIQUAND C; GERMAIN D; GILLY R; NICOLAS A
    Pediatrie; 1960; 15():433-8. PubMed ID: 13799774
    [No Abstract]   [Full Text] [Related]  

  • 39. [Study of serotherapy of tetanus patients in our clinic for the past 30 years and the prognosis].
    KAMOSHITA S; FUKUYAMA S
    Paediatr Jpn; 1963 Mar; 67():128-32. PubMed ID: 13962124
    [No Abstract]   [Full Text] [Related]  

  • 40. [Cortisone associated with specific serotherapy in tetanus in children].
    RAGAZZINI F
    Riv Clin Pediatr; 1956 Mar; 57(Suppl 3):630-1. PubMed ID: 13371227
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.